Enteral nutrition formula selection: Current evidence and implications for practice

Nutrition in Clinical Practice

Volumn 30, Issue 1, 2015, Pages 72-85

  Brown, Britta ^a   Roehl, Kelly ^b   Betz, Melanie ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

enteral formula; enteral nutrition; formulated food; medical food; nutrition therapy; nutritional support; pharmaconutrition; tube feeding

Indexed keywords

ARGININE; FISH OIL; GLUTAMINE; NUCLEOTIDE; OMEGA 3 FATTY ACID; TRACE ELEMENT; IMMUNOLOGICAL ADJUVANT;

BARIATRICS; CLINICAL PRACTICE; DIABETES MELLITUS; ELEMENTAL DIET; ENTERIC FEEDING; EVIDENCE BASED PRACTICE; FIBER; FOOD AND DRUG ADMINISTRATION; GLUCOSE INTOLERANCE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; IMMUNOMODULATION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MACRONUTRIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; CRITICAL ILLNESS; DRUG EFFECTS; IMMUNE SYSTEM; PROCEDURES; STANDARDS; TREATMENT OUTCOME; UNITED STATES;

ADJUVANTS, IMMUNOLOGIC; CRITICAL ILLNESS; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; IMMUNE SYSTEM; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84921444837     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533614561791     Document Type: Review

References (96)

1. U.S. Food and Drug Administration. Draft guidance for industry: Frequently asked questions about medical foods. 2nd ed.2013. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/MedicalFoods/ucm054048.htm. Accessed March 30, 2014.
2. Campbell S. An anthology of advances in enteral tube feeding formulations. Nutr Clin Pract. 2006 ; 21: 411-415
3. Nestlé Health Science. Impact®. 2013. http://www.nestlehealthscience.us/products/impact%C2%AE. Accessed April 7, 2014.
4. Abbott Nutrition. Pivot® 1.5 Cal. 2014. http://abbottnutrition.com/brands/products/pivot-1-5-cal. Accessed April 7, 2014.
5. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2012. Washington, DC: U.S. Department of Agriculture, Agricultural Research Service ; 2011 :
6. Wiesen P, Van Gossum A, Preiser JC. Diarrhoea in the critically ill. Curr Opin Crit Care. 2006 ; 12 (2). 149-154
7. Shankardass K, Chuchmach S, Chelswick K, et al. Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr. 1990 ; 14 (5). 508-512
8. Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008 ; 27 (2). 120-145
9. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009 ; 33 (3). 277-316
10. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995 ; 125 (6). 1401-1412
11. Garleb K, Snook J, Marcon M, Wolf B, Johnson W. Effect of fructooligosaccharide containing enteral formulas on subjective tolerance factors, serum chemistry profiles, and faecal bifidobacteria in healthy adult male subjects. Microbiol Ecol Health Dis. 1996 ; 9: 279-285
12. Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr. 2005 ; 135 (8). 1896-1902
13. Vandewoude MF, Paridaens KM, Suy RA, Boone MA, Strobbe H. Fibre-supplemented tube feeding in the hospitalised elderly. Age Ageing. 2005 ; 34 (2). 120-124
14. Visek J, Zourek M, Lacigova S, Rusavy Z. Influence of fiber on glycemic index of enteral nutrition. JPEN J Parenter Enteral Nutr. 2007 ; 31 (6). 491-495
15. Scaife CL, Saffle JR, Morris SE. Intestinal obstruction secondary to enteral feedings in burn trauma patients. J Trauma. 1999 ; 47 (5). 859-863
16. McClave SA, Chang W-K. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel?. Nutr Clin Pract. 2003 ; 18: 279
17. Novak P, Wilson KE, Ausderau K, Cullinane D. The use of blenderized tube feedings. ICAN Infant Child Adolesc Nutr. 2009 ; 1 (21). 21-23
18. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutrition support and use of diabetes-specific formulas for patients with diabetes. Diabetes Care. 2005 ; 28: 2267-2279
19. Abbott Nutrition. Glucerna®. 2014. http://abbottnutrition.com/brands/products/glucerna-1-2-cal. Accessed April 14, 2014.
20. Nestlé Health Science. Glytrol®. 2013. http://www.nestlehealthscience.us/products/glytrol%C2%AE. Accessed April 14, 2014.
21. Position. Diabetes Care. 2008 ; 31: S61 - S131
22. McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. Clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013 ; 37: 23-36
23. Leon-Sanz M, Garcia-Luna PP, Planas M, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN J Parenter Enteral Nutr. 2005 ; 29: 21-29
24. Mesejo A, Acosta JA, Ortega J, et al. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr. 2003 ; 22: 295-305
25. Academy of Nutrition and Dietetics. Evidence Analysis Library. Diseases/health conditions>diabetes 1 and 2>enteral nutrition and DM. 2014. http://andevidencelibrary.com/topic.cfm?cat=3019. Accessed March 31, 2014.
26. Abbott Nutrition. Nepro®. 2014. http://abbottnutrition.com/brands/products/nepro-with-carb-steady. Accessed April 29, 2014.
27. Abbott Nutrition. Suplena®. 2014. http://abbottnutrition.com/brands/products/suplena-with-carb-steady. Accessed April 29, 2014.
28. Nestlé Health Science. Novasource Renal®. 2013. http://www.nestlehealthscience.us/products/Pages/NOVASOURCE%C2%AE-RENAL.aspx. Accessed April 29, 2014.
29. Stratton RJ, Bircher G, Fouque D, et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2005 ; 46: 387-405
30. Holley JL, Kirk J. Enteral tube feeding in a cohort of chronic hemodialysis patients. J Renal Nutr. 2002 ; 12: 177-182
31. Brown RO, Compher C. A.S.P.E.N. Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010 ; 34: 366-377
32. Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006 ; 25: 295-310
33. Cresci G, Lefton J, Halasa Esper D The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 2 nd ed.Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2012:186-205. Mueller CM, ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition ; 2012: 186-205.
34. DiCecco SR, Francisco-Ziller N. Nutrition in alcoholic liver disease. Nutr Clin Pract. 2006 ; 21: 245-254
35. Plauth M, Cabré E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006 ; 25: 285-294
36. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012 ; 5: CD008344
37. Córdoba J, López-Hellín J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004 ; 41: 38-43
38. Kearns PJ, Young H, Garcia G, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 1992 ; 102: 200-205
39. Blei AT, Córdoba J. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2001 ; 96: 1968-1975
40. Dickerson RN, Rosato EF, Mullen JL. Net protein anabolism with hypocaloric parenteral nutrition in obese stressed patients. Am J Clin Nutr. 1986 ; 44: 747-755
41. McCowan KC, Friel C, Sternberg J, et al. Hypocaloric total parenteral nutrition: Effectiveness in prevention of hyperglycemia and infectious complications: a randomized clinical trial. Crit Care Med. 2000 ; 28: 3606-3611
42. Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition. 2002 ; 18: 241-246
43. Burge JC, Goon A, Choban PS. Efficacy of hypocaloric total parenteral nutrition in hospitalized obese patients: a prospective, double-blind randomized trial. JPEN J Parenter Enteral Nutr. 1994 ; 18: 203-207
44. Choban PS, Burge JC, Scales D, Flancbaum L. Hypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application. Am J Clin Nutr. 1997 ; 66: 546-550
45. Choban PS, Dickerson RN. Morbid obesity and nutrition support: is bigger different?. Nutr Clin Pract. 2005 ; 20: 480-487
46. Dickerson RN, Medling TL, Smith AC, et al. Hypocaloric, high-protein nutrition therapy in older vs younger critically ill patients with obesity. JPEN J Parenter Enteral Nutr. 2013 ; 37: 342-351
47. Choban P, Dickerson R, Malone A, Worthington P, Compher C. American Society for Parenteral and Enteral Nutrition. A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity. JPEN J Parenter Enteral Nutr. 2013 ; 37: 714-744
48. Nestlé Health Science. Peptamen Bariatric®. 2013. http://www.nestlehealthscience.us/products/peptamen%C2%AE-bariatric. Accessed April 12, 2014.
49. Academy of Nutrition and Dietetics. Evidence Analysis Library. Diseases/health conditions>critical illness> hypocaloric feeding regimen. 2014. http://andevidencelibrary.com/topic.cfm?cat=4765. Accessed April 14, 2014.
50. Tiengou LE, Gloro R, Pouzoulet J, et al. Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study. JPEN J Parenter Enteral Nutr. 2006 ; 30 (1). 1-5
51. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007 ; 119 (1). 184-191
52. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet. 1990 ; 335: 816-819
53. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr. 2006 ; 25 (2). 260-274
54. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 ; (1). CD000542
55. Lee J, Allen R, Ashley S, et al. Gastroenterology Specialist Group of the British Dietetic Association. J Hum Nutr Diet. 2014 ; 27 (3). 207-218
56. Chen Y, Peterson SJ. Enteral nutrition formulas: which formula is right for your adult patient?. Nutr Clin Pract. 2009 ; 24 (3). 344-355
57. Calder PC. n-3 polyunsaturated fatty acids, inflammation and inflammatory diseases. Am J Clin Nutr. 2006 ; 83 (6). S1505-1519S
58. Matsuyama W, Mitsuyama H, Watanabe M, et al. effects of omega-3 polyunsaturated fatty acids on markers inflammatory markers in COPD. Chest. 2005 ; 128: 3817-3827
59. Vermeeren MA, Wouters EF, Nelissen LH, van Lier A, Hofman Z, Schols AM. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2001 ; 73 (2). 295-301
60. Van den Berg B, Bogaard J, Hop W. High fat, low carbohydrate, enteral feeding in patients weaning from the ventilator. Intensive Care Med. 1994 ; 20 (7). 470-475
61. Angelillo VA, Bedis S, Durfree D, Dahl J, Patterson AJ, O'Donohue WJ. Effects of low and high carbohydrate feedings in ambulatory patients with chronic obstructive pulmonary disease and chronic hypercapnia. Ann Intern Med. 1985 ; 103 (6, pt 1). 883-885
62. Kuo C, Shiao G, Lee J. The effects of high-fat and high-carbohydrate diet loads on gas exchange and ventilation in COPD patients and normal subjects. Chest J. 1993 ; 104 (1). 189-196
63. Cai B, Zhu Y, Ma Y, et al. Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients. Nutrition. 2003 ; 19 (3). 229-232
64. Al-Saady N, Blackmore C, Bennett E. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989 ; 15 (5). 290-295
65. Talpers SS, Romberger D, Bunce SB, Pingleton SK. Nutritionally associated increased carbon dioxide production: excess total calories vs high proportion of carbohydrate calories. Chest J. 1992 ; 102 (2). 551-555
66. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006 ; 34 (4). 1033-1038
67. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006 ; 34 (9). 2325-2333
68. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999 ; 27 (8). 1409-1420
69. Cohen D, Byham-Gray L, Denmark R. Impact of two pulmonary enteral formulations on nutritional indices and outcomes. J Hum Nutr Diet. 2013 ; 26 (3). 286-293
70. Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, γ-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011 ; 306 (14). 1574
71. Desai SV, McClave SA, Rice TW. Nutrition in the ICU: an evidence-based approach. Chest J. 2014 ; 145 (5). 1148-1157
72. Glenn JO, Wischmeyer PE. Enteral fish oil in critical illness: perspectives and systematic review. Curr Opin Clin Nutr Metab Care. 2014 ; 17 (2). 116-123
73. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 ; 39 (2). 165-228
74. Drover JW, Dhaliwal R, Weitzel L, Wischmeyer PE, Ochoa JB, Heyland DK. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg. 2011 ; 212 (3). 385-399
75. Strickland A, Brogan A, Krauss J, Martindale R, Cresci G. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. JPEN J Parenter Enteral Nutr. 2005 ; 29 (1). S81 - S91
76. Braga M, Gianotti L. Preoperative immunonutrition: cost-benefit analysis. JPEN J Parenter Enteral Nutr. 2005 ; 29 (1). S57 - S61
77. Vidal-Casariego A, Calleja-Fernandez A, Villar-Taibo R, Kyriakos G, Ballesteros-Pomar MD. Efficacy of arginine-enriched enteral formulas in the reduction of surgical complications in head and neck cancer: a systematic review and meta-analysis. Clin Nutr. 2014 ;:
78. Sunpaweravong S, Puttawibul P, Ruangsin S, et al. Randomized study of anti-inflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. Nutr Cancer. 2014 ; 66 (1). 1-5
79. Pontes-Arruda A, Martins LF, de Lima SM, et al. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011 ; 15: R144
80. Machado FR. Fish oil and sepsis: we still need more trials. Crit Care. 2011 ; 15 (5). 449
81. Machado FR, Caldeira-Filho M, Costa-Filho R, et al. INTERSEPT study: we still need more clarity. Crit Care. 2012 ; 16 (2). 1-2
82. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999 ; 27 (8). 1409-1420
83. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999 ; 27 (12). 2799-2805
84. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001 ; 286 (8). 944-953
85. Montejo JC, Zarazaga A, López-Martínez J, et al. Immunonutrition in the intensive care unit: a systematic review and consensus statement. Clin Nutr. 2003 ; 22 (3). 221-233
86. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008 ; 34 (11). 1980-1990
87. Kreymann KG, Berger MM, Deutz NE, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006 ; 25 (2). 210-223
88. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013 ; 368 (16). 1489-1497
89. van Zanten ARH, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients versus standard-high protein enteral nutrition and nosocomial infections in the ICU. JAMA. 2014 ; 312 (5). 514-524
90. Andrews PJD, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2001 ; 342: 1-8
91. Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014 ; 18: R76
92. Chen QH, Yan Y, He HL, et al. The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care. 2014 ; 18: R8
93. Perez-Barcena J, Marse P, Zabalegui-Parez A, et al. A randomized trial of intravenous glutamine supplementation in trauma ICU patients. Intensive Care Med. 2014 ; 40 (4). 539-547
94. Ochoa JB, McClave SA, Saavedra J. Issues involved in the process of developing a medical food. JPEN J Parenter Enteral Nutr. 2011 ; 35: 73S - 79S
95. Academy of Nutrition and Dietetics. Nutrition Care Manual. 2014. http://www.nutritioncaremanual.org/formulary. Accessed March 31, 2014.
96. Nestlé Health Science. Medicare Coverage of Enteral Nutrition Therapy: An Informational Primer. 2012. http://www.nestle-nutrition.com/nirf/cm2/upload/34032791-C22A-42F6-9A91-E7AE8A405B56/Informational-Primer-Medicare-Coverage-of-Enteral-Therapy.pdf. Accessed April 12, 2014.